| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.011 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0042 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |